Final results of a randomized, open label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC.
暂无分享，去创建一个
Manal M. Hassan | P. Sharma | J. Vauthey | A. Rashid | J. Blando | J. Allison | R. Wolff | M. Hassan | D. Duda | A. Qayyum | L. Vence | H. Amin | H. T. Cao | Y. Chun | A. Kaseb | James C. Yao | R. Pestana | Y. Abugabal | Shalini Singh | C.D. Tzeng | D. Sakamuri | J. Yao | C. Tzeng